Skip to content

Effect of Dexamethasone on Post-spinal Hypotension

Effect of Dexamethasone on Post-spinal Hypotension in Geriatric Patients Undergoing Orthopaedic Surgery at Tertiary Care Hospital Karachi.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06819436
Enrollment
170
Registered
2025-02-11
Start date
2025-02-28
Completion date
2025-05-31
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric Population, Orthopedic Surgeries, Post Spinal Anaesthesia Hypotension

Brief summary

The goal of this clinical trial is to learn if intravenous dexamethasone is effective for prevention of post spinal hypotension in geriatric population undergoing orthopedic surgeries. The main question aim to answer is: Does intravenous dexamethasone in participants undergoing orthopedic procedures of lower limb under spinal anesthesia prevents post spinal hypotension? Researchers are comparing two groups of participants * Participants in (Dexamethasone Group) Group D are receiving intravenous dexamethasone 8mg preoperatively * Participants in (Placebo Group) Group P are receiving placebo preoperatively.

Interventions

DRUGDexamethasone

Intravenous dexamethasone 8mg given to participants before spinal anesthesia

OTHERPlacebo

Intravenous placebo given to the participants before spinal anesthesia

Sponsors

Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

Patient undergoing orthopedic surgery in spinal anesthesia. ASA ≤ 2.

Exclusion criteria

Patients with history of cardiac arrhythmias. Patients with history of acute coronary syndrome. Patient with history of polytrauma. Patients with contraindication to SA (e.g., coagulopathy, thrombocytopenia, allergy to local anesthetic agent) and those on steroids or serotonin related medications (e.g., selective serotonin reuptake inhibitor) will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Post spinal Anesthesia HypotensionFrom enrollment to 30 minutes after spinal anesthesiaHypotension will be considered if there will be 25% decrease below the baseline for (Mean Arterial Pressure) MAP and will be managed by 300 ml of (Normal Saline) NS solution with incremental intravenous 5 mg doses of ephedrine. The proportion of patients with hypotension at any time during the first 20 min after induction of the (Spinal Anesthesia) SA and before starting the surgical procedure will be considered as the outcome of the study.

Countries

Pakistan

Contacts

Primary ContactSidra Javed, MBBS, FCPS, Pain fellow
sidra_dow@yahoo.com+92333 2474831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026